Mason Archival Repository Service

Essays on the Drug Discovery Innovation System

Show simple item record

dc.contributor.advisor Hart, David M Sarkissian, Alfred
dc.creator Sarkissian, Alfred 2018-10-22T01:20:33Z 2018-10-22T01:20:33Z 2017
dc.description.abstract Despite the increase in scientific, monetary, and human resources devoted to drug discovery R&D, the annual number of FDA-approved drugs has been almost unchanged for decades. This study seeks clues to the R&D productivity paradox by exploring the drivers and barriers to innovation in the pharmaceutical industry. The main focus is on the contribution of science and knowledge form external sources to innovation.
dc.format.extent 294 pages
dc.language.iso en
dc.rights Copyright 2017 Alfred Sarkissian
dc.subject Public policy en_US
dc.subject Breakthrough Innovations en_US
dc.subject Drug Discovery Innovation en_US
dc.subject Eroom’s Law en_US
dc.subject Innovation System en_US
dc.subject Orange Book en_US
dc.subject Patent Analysis en_US
dc.title Essays on the Drug Discovery Innovation System
dc.type Dissertation Ph.D. Public Policy George Mason University

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MARS


My Account